trimethoprim has been researched along with Mycoses in 32 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Mycoses: Diseases caused by FUNGI.
Excerpt | Relevance | Reference |
---|---|---|
"The efficacy and safety of norfloxacin were compared with those of placebo, vancomycin-polymyxin, and trimethoprim-sulfamethoxazole (TMP/SMX) for prophylaxis of bacterial infections in granulocytopenic patients." | 9.06 | Norfloxacin for prevention of bacterial infections in granulocytopenic patients. ( Bartlett, J; Champlin, RE; Deresinski, S; Finley, RS; Ho, WG; Joshi, JH; Karp, J; Levitt, L; Talbot, G; Winston, DJ, 1987) |
"In a comparative study of infection prophylaxis, patients with acute leukemia receiving remission induction therapy were assigned either no prophylaxis, sulfamethoxazole and trimethoprim, ketoconazole, or the combination of sulfamethoxazole and trimethoprim and ketoconazole." | 9.05 | Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two. ( Bodey, GP; Estey, E; Fainstein, V; Freireich, EJ; Keating, M; Maksymiuk, A; McCredie, KB; Smith, T, 1984) |
"The efficacy and safety of norfloxacin were compared with those of placebo, vancomycin-polymyxin, and trimethoprim-sulfamethoxazole (TMP/SMX) for prophylaxis of bacterial infections in granulocytopenic patients." | 5.06 | Norfloxacin for prevention of bacterial infections in granulocytopenic patients. ( Bartlett, J; Champlin, RE; Deresinski, S; Finley, RS; Ho, WG; Joshi, JH; Karp, J; Levitt, L; Talbot, G; Winston, DJ, 1987) |
"Eighty-four cancer patients at risk of infection because of neutropenia were randomized to receive nalidixic acid as an alternative to trimethoprim-sulfamethoxazole (TMP-SMX) for infection prophylaxis." | 5.06 | Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration. ( Bow, EJ; Louie, TJ; Rayner, E; Scott, BA, 1987) |
"In a comparative study of infection prophylaxis, patients with acute leukemia receiving remission induction therapy were assigned either no prophylaxis, sulfamethoxazole and trimethoprim, ketoconazole, or the combination of sulfamethoxazole and trimethoprim and ketoconazole." | 5.05 | Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two. ( Bodey, GP; Estey, E; Fainstein, V; Freireich, EJ; Keating, M; Maksymiuk, A; McCredie, KB; Smith, T, 1984) |
"Sixty-two profoundly granulocytopenic patients with acute leukemia undergoing induction chemotherapy were prospectively randomized to receive either trimethoprim-sulfamethoxazole plus nystatin or nalidixic acid plus nystatin for prevention of infection." | 5.05 | Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid. ( Crowley, J; de Jongh, CA; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH, 1983) |
" From the published evidence, the most promising associations are, for staphylococcal infections, gentamicin, erythromycin, kanamycin and fusidic acid." | 4.76 | Clinical use of rifampicin in combination for non-mycobacterial infections: a survey of published evidence. ( Fowst, G; Nessi, R, 1979) |
"Ketoconazole or miconazole was randomly administered to 42 and 46 neutropenic patients respectively." | 2.65 | Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients. ( Cruciani, M; Klastersky, J; Meunier-Carpentier, F, 1983) |
"Although the incidence of bacterial infections in the two groups was not statistically significantly different, almost twice as many bacterial infections were observed in the group that received the short course of empirical therapy." | 2.65 | Empirical antibacterial therapy in febrile, granulocytopenic bone marrow transplant patients. ( Goldman, AI; Kersey, J; McGlave, P; Peterson, PK; Ramsay, NK; Rhame, F, 1984) |
" The long-term use of trimethoprim-sulfamethoxazole and ketoconazole as a preventive therapy for infections has also been evaluated." | 1.28 | Incidence, severity, and prevention of infections in chronic granulomatous disease. ( Fischer, A; Griscelli, C; Mouy, R; Seger, R; Vilmer, E, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 29 (90.63) | 18.7374 |
1990's | 2 (6.25) | 18.2507 |
2000's | 1 (3.13) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kocatürk, T | 1 |
Pineda, R | 1 |
Green, LK | 1 |
Azar, DT | 1 |
Estey, E | 1 |
Maksymiuk, A | 1 |
Smith, T | 1 |
Fainstein, V | 1 |
Keating, M | 1 |
McCredie, KB | 1 |
Freireich, EJ | 1 |
Bodey, GP | 1 |
Watson, JG | 1 |
Jameson, B | 1 |
Powles, RL | 1 |
McElwain, TJ | 1 |
Lawson, DN | 1 |
Judson, I | 1 |
Morgenstern, GR | 1 |
Lumley, H | 1 |
Kay, HE | 1 |
Rogers, TR | 1 |
Meunier-Carpentier, F | 1 |
Cruciani, M | 1 |
Klastersky, J | 1 |
Bow, EJ | 2 |
Louie, TJ | 3 |
Riben, PD | 2 |
McNaughton, RD | 1 |
Harding, GK | 1 |
Ronald, AR | 2 |
Winston, DJ | 2 |
Ho, WG | 2 |
Champlin, RE | 2 |
Gale, RP | 1 |
Peterson, PK | 1 |
McGlave, P | 1 |
Ramsay, NK | 1 |
Rhame, F | 1 |
Goldman, AI | 1 |
Kersey, J | 1 |
Hendriks, WD | 1 |
Sizoo, W | 1 |
Löwenberg, B | 1 |
Hagenbeek, A | 1 |
Okafor, BC | 1 |
Gugnani, HC | 1 |
Kauffman, CA | 1 |
Liepman, MK | 1 |
Bergman, AG | 1 |
Mioduszewski, J | 1 |
Wade, JC | 1 |
de Jongh, CA | 1 |
Newman, KA | 1 |
Crowley, J | 1 |
Wiernik, PH | 1 |
Schimpff, SC | 1 |
Meares, EM | 1 |
Giamarellou, H | 1 |
Bambule, J | 1 |
Millioud, E | 1 |
Grigoriu, D | 1 |
Nessi, R | 1 |
Fowst, G | 1 |
Singh, D | 1 |
Kochhar, RC | 1 |
Seth, HN | 1 |
Havas, L | 1 |
Vilde, JL | 1 |
Leport, C | 1 |
Takabayashi, K | 1 |
Koike, T | 1 |
Kurasawa, K | 1 |
Yamazaki, S | 1 |
Sugiyama, T | 1 |
Matsumura, R | 1 |
Yoshida, H | 1 |
Tomioka, H | 1 |
Yoshida, S | 1 |
Ohshima, H | 1 |
Mouy, R | 1 |
Fischer, A | 1 |
Vilmer, E | 1 |
Seger, R | 1 |
Griscelli, C | 1 |
Günther, I | 1 |
Kaben, U | 1 |
Dunker, H | 1 |
Brijmohan-Günther, R | 1 |
Konrad, H | 1 |
Karp, J | 1 |
Bartlett, J | 1 |
Finley, RS | 1 |
Joshi, JH | 1 |
Talbot, G | 1 |
Levitt, L | 1 |
Deresinski, S | 1 |
Otis, LL | 1 |
Terezhalmy, GT | 1 |
Rayner, E | 1 |
Scott, BA | 1 |
Young, LS | 1 |
Hughes, WT | 2 |
Rivera, GK | 1 |
Schell, MJ | 1 |
Thornton, D | 1 |
Lott, L | 1 |
Buchanan, AG | 1 |
Rayner, EN | 1 |
Parker, SE | 1 |
Feldman, S | 1 |
Gigliotti, F | 1 |
Shenep, J | 1 |
Sixbey, J | 1 |
Spitzer, G | 1 |
Garson, OM | 1 |
Marks, MI | 1 |
Shapera, RM | 1 |
Brazeau, M | 1 |
Roy, AD | 1 |
Cameron, HM | 1 |
7 reviews available for trimethoprim and Mycoses
Article | Year |
---|---|
Infectious complications of bone marrow transplantation.
Topics: Aminoglycosides; Amphotericin B; Anemia, Aplastic; Bacterial Infections; Bone Marrow Transplantation | 1984 |
[Bacteriologic management of patients with decreased resistance].
Topics: Agranulocytosis; Anti-Bacterial Agents; Antisepsis; Bacterial Infections; Drug Combinations; Humans; | 1984 |
Prostatitis and related diseases.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteriological Techniques; Cal | 1980 |
Empiric therapy for infections in the febrile, neutropenic, compromised host.
Topics: Algorithms; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; | 1995 |
Clinical use of rifampicin in combination for non-mycobacterial infections: a survey of published evidence.
Topics: Amphotericin B; Cephalosporins; Chloramphenicol; Colistin; Drug Therapy, Combination; Endocarditis, | 1979 |
[Antibiotherapy in chronic familial granulomatosis].
Topics: Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Drug Combination | 1990 |
Prevention of infectious complications in acute lymphoblastic leukemia.
Topics: Acute Disease; Acyclovir; Anti-Bacterial Agents; Bacterial Infections; Catheterization; Chickenpox; | 1985 |
10 trials available for trimethoprim and Mycoses
Article | Year |
---|---|
Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Drug Combinations; Drug Therapy, Combi | 1984 |
Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia.
Topics: Acute Disease; Anti-Bacterial Agents; Bone Marrow Transplantation; Clinical Trials as Topic; Colisti | 1982 |
Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients.
Topics: Agranulocytosis; Antifungal Agents; Candidiasis; Drug Combinations; Female; Humans; Imidazoles; Keto | 1983 |
Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients.
Topics: Adult; Agranulocytosis; Bacteria; Bacterial Infections; Clinical Trials as Topic; Drug Combinations; | 1984 |
Empirical antibacterial therapy in febrile, granulocytopenic bone marrow transplant patients.
Topics: Adolescent; Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Bone Marrow Transpl | 1984 |
Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Bacteria; Bacterial Infections; Drug Resistance | 1983 |
Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Child; Drug Combinations; Female; Hu | 1983 |
Norfloxacin for prevention of bacterial infections in granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Drug Combinations; Drug Therapy, Com | 1987 |
Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
Topics: Agranulocytosis; Antineoplastic Agents; Bacteria; Bacterial Infections; Clinical Trials as Topic; Dr | 1987 |
Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis.
Topics: Anti-Infective Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Eva | 1987 |
15 other studies available for trimethoprim and Mycoses
Article | Year |
---|---|
Post-LASIK epithelial dendritic defect associated with Alternaria.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Corneal Ulcer; Debridement | 2007 |
Infection complicating bone marrow transplantation: what are the risks and can they be reduced?
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacterial Infections; Blood | 1982 |
Nasal entomophthoromycosis in Nigerian Igbos.
Topics: Adult; Drug Combinations; Entomophthora; Female; Humans; Male; Middle Aged; Mycoses; Nigeria; Nose D | 1983 |
[Bacterial and fungal rhino-sinusitis].
Topics: Amphotericin B; Ampicillin; Aspergillus fumigatus; Bacterial Infections; Erythromycin; Humans; Mycos | 1977 |
Rhinoentomophthoromycosis.
Topics: Adult; Entomophthora; Fungi; Humans; Male; Mycoses; Nose Diseases; Potassium Iodide; Prednisolone; S | 1976 |
[The treatment of various deep mycoses (South American blastomycosis, nocardiosis, actinomycetoma) with the drug combination sulfamethoxazole+trimethoprim (bactrim, septrin). Review of the literature].
Topics: Actinomycetales; Actinomycetales Infections; Blastomyces; Blastomycosis; Dapsone; Drug Combinations; | 1975 |
[Pulmonary opportunistic infections in patients with autoimmune diseases].
Topics: Adult; Aged; Autoimmune Diseases; Female; Humans; Isoniazid; Lung Diseases, Fungal; Male; Middle Age | 1989 |
Incidence, severity, and prevention of infections in chronic granulomatous disease.
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Drug Combinations; Genetic Linkage; Granu | 1989 |
Selective decontamination of the digestive tract and fungal infection in acute leukemia patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Digestive System; Drug Administration | 1988 |
The granulocytopenic patient: another consideration for antimicrobial prophylaxis.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Dental Care for Disabled; Humans; Mout | 1985 |
Management of opportunistic infections complicating the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Cryptococcosis; Drug Combinations; Humans; I | 1986 |
Nystatin prophylaxis of fungal colonization and infection in granulocytopenic patients: correlation of colonization and clinical outcome.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Drug Combinations; Female; Fever; H | 1985 |
Lymphoblastic leukemia with marked eosinophilia: a report of two cases.
Topics: Adolescent; Blood Cell Count; Bone Marrow Examination; Cytarabine; Eosinophilia; Female; Humans; Kar | 1973 |
Pediatric antimicrobial therapy. V.
Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Bacterial Infections; Child; Drug Therapy, | 1973 |
Rhinophycomycosis entomophthorae occurring in a chimpanzee in the wild in East Africa.
Topics: Africa, Eastern; Animals; Disease Models, Animal; Female; Fungi; Mycoses; Nose; Nose Diseases; Pan t | 1972 |